361 related articles for article (PubMed ID: 4280163)
1. Prolonged remission of severe aplastic anemia after ALG pretreatment and HL-A-semi-incompatible bone-marrow cell transfusion.
Jeannet M; Rubinstein A; Pelet B; Kummer H
Transplant Proc; 1974 Dec; 6(4):359-63. PubMed ID: 4280163
[No Abstract] [Full Text] [Related]
2. Possible role of lymphocyte cytotoxicity in bone-marrow grafting.
Oldham RK; Simmler MC
Transplant Proc; 1974 Dec; 6(4):417-9. PubMed ID: 4280166
[No Abstract] [Full Text] [Related]
3. [Immunosuppression, bone marrow infusion and low dose androgens, successful therapy of severe aplastic anemia].
Cornu P; Speck B; Gratwohl A; Nissen C; Sartorius J; Jeannet M
Schweiz Med Wochenschr; 1979 Sep; 109(37):1384-5. PubMed ID: 384511
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic marrow transplantation using matched sibling donors.
Thomas ED
Transplant Proc; 1974 Dec; 6(4 Suppl 1):115-9. PubMed ID: 4155158
[No Abstract] [Full Text] [Related]
5. Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerism.
Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Belpomme D; Jasmin C; Rosenfeld C; Hayat M; de Vassal F; Steresco M
Transplant Proc; 1972 Dec; 4(4):551-7. PubMed ID: 4566797
[No Abstract] [Full Text] [Related]
6. Autologous marrow reconstitutions in severe aplastic anaemia after ALG pretreatment and HL-A semi-incompatible bone marrow cell transfusion.
Jeannet M; Speck B; Rubinstein A; Pelet B; Wyss M; Kummer H
Acta Haematol; 1976; 55(3):129-39. PubMed ID: 816150
[TBL] [Abstract][Full Text] [Related]
7. Evidence for new histocompatibility loci in man [proceedings].
Goldmann SF; Kristensen T; Grunnet N; Kissmeyer-Nielsen F
Z Immunitatsforsch Immunobiol; 1976 Dec; 152(4):335-7. PubMed ID: 137604
[No Abstract] [Full Text] [Related]
8. Bone marrow transplantation for the treatment of severe aplastic anaemia.
Spruce W; McMillan R; Beutler E
Clin Haematol; 1983 Feb; 12(1):285-310. PubMed ID: 6340884
[No Abstract] [Full Text] [Related]
9. [Treatment of bone marrow aplasia by allogenic bone marrow grafts].
Gluckman E; Bussel A; Benbunan M; Broquet MA; Schaison G; Dausset J; Bernard J
Nouv Presse Med; 1975 Apr; 4(16):1177-82. PubMed ID: 240152
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of severe aplastic anemia].
Gratwohl A; Osterwalder B; Nissen C; Leibundgut U; Signer E; Lüthy A; Jeannet M; Speck B
Schweiz Med Wochenschr; 1981 Oct; 111(41):1520-2. PubMed ID: 7031870
[TBL] [Abstract][Full Text] [Related]
11. Unrelated donors for bone-marrow transplantation and transfusion support: pool sizes required.
Opelz G; Mickey MR; Terasaki PI
Transplant Proc; 1974 Dec; 6(4):405-9. PubMed ID: 4280165
[No Abstract] [Full Text] [Related]
12. Bone marrow transplantation in aplastic anaemia.
Mullins GM; Greally JF; O'Toole M; Temperley IJ
Ir J Med Sci; 1976 May; 145(5):156-62. PubMed ID: 14087
[No Abstract] [Full Text] [Related]
13. Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin--long-term results.
Mathé G; Schwarzenberg L
Transplant Proc; 1976 Dec; 8(4):595-602. PubMed ID: 136773
[TBL] [Abstract][Full Text] [Related]
14. [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].
Zwaan FE; Haak HL; van der Meer CW; Guiot HF; Hartgrink-Groeneveld CA; den Ottolander GJ; Willemze R; Eernisse JG; Brand A; van Rood JJ; Kunst MW; te Velde J; Noordwijk EM
Ned Tijdschr Geneeskd; 1978 Mar; 122(10):326-32. PubMed ID: 24811
[No Abstract] [Full Text] [Related]
15. Bone marrow graft versus ALG in patients with aplastic anaemia.
Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
Biomed Pharmacother; 1983; 37(3):139-43. PubMed ID: 6357304
[TBL] [Abstract][Full Text] [Related]
16. Treatment of severe aplastic anemia with antilymphocyte globulin and androgens.
Gluckman E; Devergie A; Faille A; Barrett AJ; Bonneau M; Boiron M; Bernard J
Exp Hematol; 1978 Sep; 6(8):679-87. PubMed ID: 361428
[TBL] [Abstract][Full Text] [Related]
17. Aplastic anemia treated by marrow transplantation.
Buckner CD; Clift RA; Fefer A; Funk DD; Glucksberg H; Ramberg RE; Storb R; Thomas ED
Transplant Proc; 1973 Mar; 5(1):913-6. PubMed ID: 4144472
[No Abstract] [Full Text] [Related]
18. Treatment of established human graft-versus-host disease by antithymocyte globulin.
Storb R; Gluckman E; Thomas ED; Buckner CD; Clift RA; Fefer A; Glucksberg H; Graham TC; Johnson FL; Lerner KG; Neiman PE; Ochs H
Blood; 1974 Jul; 44(1):56-75. PubMed ID: 4275768
[No Abstract] [Full Text] [Related]
19. Selection of patients for bone marrow transplantation in severe aplastic anemia.
Camitta BM; Rappeport JM; Parkman R; Nathan DG
Blood; 1975 Mar; 45(3):355-63. PubMed ID: 1090310
[TBL] [Abstract][Full Text] [Related]
20. Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia.
Speck B; Buckner CD; Cornu P; Jeannet B
Transplant Proc; 1976 Dec; 8(4):617-22. PubMed ID: 11593
[No Abstract] [Full Text] [Related]
[Next] [New Search]
